Aferetica is an innovative Start Up, founded by managers with experience in dialysis, intensive care, cardiology, in order to drive and incentive the creation of a network, which must be able to create, validate and use apheresis therapies in clinical practice, initiating their use in new clinical areas.
Aferetica endeavors to develop systems for both, perfusion and depuration, of organs for transplantation. Today, a shortage of organs for transplantation is opposed to the even higher demand.
Organ perfusion techniques have been proposed to improve the "usability". Aferetica intends to enhance organ suitability for transplantation by combining perfusion and a patented apheresis purification system.